Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Nellore cattle have genetic variations linked to their adaptation to tropical environments.

Understanding how our bodies interact with mosquito-borne viruses is crucial because there are few treatments and vaccines.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.